Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

GlaxoSmithKline plc (GSK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
45.25-0.49 (-1.07%)
At close: 04:00PM EST
45.24 -0.01 (-0.02%)
After hours: 07:41PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close45.74
Open45.24
Bid45.09 x 1300
Ask45.19 x 1800
Day's Range44.82 - 45.31
52 Week Range33.53 - 46.86
Volume3,858,685
Avg. Volume4,205,200
Market Cap113.844B
Beta (5Y Monthly)0.38
PE Ratio (TTM)19.71
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield2.20 (4.80%)
Ex-Dividend DateNov 18, 2021
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-13% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for GSK

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • GlaxoSmithKline PLC
    Analyst Report: GlaxoSmithKline plcIn the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.
    Rating
    Fair Value
    Economic Moat
    11 days agoMorningstar
View more
Advertisement
Advertisement